Fragment-Based Discovery of Inhibitors of Protein Kinase B

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 18, 2009-12 ,pp. : 1705-1717

Bentham Science Publishers

Access to resources Recommend Favorite

From Fragment Screening to Potent Binders: Strategies for Fragment-to-Lead Evolution

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 8, 2009-07 ,pp. : 956-961

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based Virtual Screening to Get New Scaffold Inhibitors of the Ser/Thr Protein Kinase PknB from Mycobacterium tuberculosis

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 10, 2016-12 ,pp. : 1012-1018

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot topic: New Insights in Protein Kinase Inhibitors: Chemogenomics, Phosphoproteomics, Structural Based Approaches and the Emergence of Resistance Executive Editor: Doriano Fabbro ]

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 3, 2004-03 ,pp. : i-i

Bentham Science Publishers

Access to resources Recommend Favorite

Protein kinase inhibitors: breakthrough medicines and the next generation

By Sawyer Tomi K  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 675-678

Informa Healthcare

Access to resources Recommend Favorite